FDA Inspection 1253764 — GSK LLC (GlaxoSmithKline)
The FDA completed an inspection of GSK LLC (GlaxoSmithKline) on Nov 22, 2024 in Collegeville, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 22, 2024
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Collegeville, PA (United States)
Additional details
Sponsor, Contract Research Organization